- The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
-
Hyun Hee Chung, Jun Sung Moon, Ji Sung Yoon, Hyoung Woo Lee, Kyu Chang Won
-
Diabetes Metab J. 2013;37(2):125-131. Published online April 16, 2013
-
DOI: https://doi.org/10.4093/dmj.2013.37.2.125
-
-
4,442
View
-
33
Download
-
14
Crossref
-
Abstract
PDF PubReader
- Background
Recently, several studies reported that the cancer incidence in type 2 diabetes patients is higher than in the general population. Although a number of risks are shared between cancer and diabetes patients, there have been few studies of its correlation. We evaluated the influences of several factors including low density lipoprotein cholesterol (LDL-C), albuminuria and use of metformin on the risk of cancer in patients with type 2 diabetes. MethodsWe enrolled 1,320 patients with at least 5 years of follow-up and 73 patients were diagnosed with cancer during this period. The associations of the risk factors with cancer incidence were evaluated by multiple regression analysis. The subjects were placed into two subgroups based on metformin dosage (<1,000 mg/day, ≥1,000 mg/day) and we compared cancer incidence using analysis of covariance. ResultsLDL-C and albuminuria were not significantly correlated with cancer risk. In contrast, metformin showed a reverse correlation with cancer risk (P=0.006; relative risk, 0.574). In the metformin nonadministration group, smoking, male gender, and high triglyceride levels tended to be contributing factors without statistical significance. Cancer occurence was lower in the low dose metformin group (less than 1,000 mg/day) (P=0.00). ConclusionThese results suggest that the administration of low dose metformin in patients with type 2 diabetes may be associated with a reduced risk of cancer.
-
Citations
Citations to this article as recorded by 
- Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model
Sudhir Manickavel, Yolanda Hartman, Andrew Burns, Manuel A. Lora Gonzalez, Jason Warram, Erika Walsh, Jacob B. Hunter, Daniel E. Killeen Otology & Neurotology.2023;[Epub] CrossRef - Metformin induces TPC-1 cell apoptosis through endoplasmic reticulum stress-associated pathways in vitro and in vivo
Jianwen Ye, Lei Qi, Kunlun Chen, Renfeng Li, Shengping Song, Chuang Zhou, Wenlong Zhai International Journal of Oncology.2019;[Epub] CrossRef - Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells
Deok-Bae Park Diabetes & Metabolism Journal.2015; 39(6): 518. CrossRef - Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia
Hsin-Hung Chen, Ming-Chia Lin, Chih-Hsin Muo, Su-Yin Yeh, Fung-Chang Sung, Chia-Hung Kao Medicine.2015; 94(24): e1013. CrossRef - mitoNEET as a novel drug target for mitochondrial dysfunction
Werner J. Geldenhuys, Thomas C. Leeper, Richard T. Carroll Drug Discovery Today.2014; 19(10): 1601. CrossRef - Diabetes - Increased Risk for Cancers through Chromosomal Aberrations?
Sudhaa Anand, Badari Nath, Radha Saraswathy Asian Pacific Journal of Cancer Prevention.2014; 15(11): 4571. CrossRef - Oleanolic Acid Induces Metabolic Adaptation in Cancer Cells by Activating the AMP-Activated Protein Kinase Pathway
Jia Liu, Lanhong Zheng, Ning Wu, Leina Ma, Jiateng Zhong, Ge Liu, Xiukun Lin Journal of Agricultural and Food Chemistry.2014; 62(24): 5528. CrossRef - Association of Vitamin B12Deficiency and Metformin Use in Patients with Type 2 Diabetes
Sun-Hye Ko, Sun-Hee Ko, Yu-Bae Ahn, Ki-Ho Song, Kyung-Do Han, Yong-Moon Park, Seung-Hyun Ko, Hye-Soo Kim Journal of Korean Medical Science.2014; 29(7): 965. CrossRef - Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini, Matteo Puntoni, Brandy M. Heckman-Stoddard, Barbara K. Dunn, Leslie Ford, Andrea DeCensi, Eva Szabo Cancer Prevention Research.2014; 7(9): 867. CrossRef - Complications of Diabetes Therapy
Sarah D. Corathers, Shawn Peavie, Marzieh Salehi Clinics Collections.2014; 1: 37. CrossRef - Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
Yanfei Zhang, Meiping Guan, Zongji Zheng, Qian Zhang, Fang Gao, Yaoming Xue, Chunming Liu PLoS ONE.2013; 8(11): e81264. CrossRef - AACE Comprehensive Diabetes Management Algorithm 2013 Endocrine Practice
Héctor Eloy Tamez-Pérez, Stephanie Lissette Proskauer-Peña, Mayra Ivonne Hernández-Coria Endocrine Practice.2013; 19(4): 736. CrossRef - Complications of Diabetes Therapy
Sarah D. Corathers, Shawn Peavie, Marzieh Salehi Endocrinology and Metabolism Clinics of North America.2013; 42(4): 947. CrossRef - Metformin and Cancer in Type 2 Diabetes
Hyeong Kyu Park Diabetes & Metabolism Journal.2013; 37(2): 113. CrossRef
- Prevalence, Awareness, and Control of Hypertension among Diabetic Koreans
-
Hyun Hee Chung, Kyu Chang Won
-
Diabetes Metab J. 2011;35(4):337-339. Published online August 31, 2011
-
DOI: https://doi.org/10.4093/dmj.2011.35.4.337
-
-
3,203
View
-
37
Download
-
6
Crossref
-
PDF PubReader
-
Citations
Citations to this article as recorded by 
- The practice of consanguineous marriage and the risk of diabetes among offspring in the province of Tetouan (Morocco)
Mohamed Hajjaji, AbdErrazzak Khadmaoui, Mohamed El Bakkali Arab Gulf Journal of Scientific Research.2024; 42(1): 30. CrossRef - ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation
Mohamed Sobhy, Adel Eletriby, Hany Ragy, Hossam Kandil, Mohamed Ayman Saleh, Nabil Farag, Ramez Guindy, Ahmed Bendary, Ahmed Mohamed Elmahmoudy Nayel, Ahmed Shawky, Ayman Khairy, Ayman Mortada, Bassem Zarif, Haitham Badran, Hazem Khorshid, Kareem Mahmoud, Cardiology and Therapy.2024; 13(4): 707. CrossRef - Insulin Resistance and Hypertension among Type 2 Diabetes Subjects in a Tertiary Institution in South East Nigeria
Michael Chinweuba Abonyi, Ekenechukwu Esther Young, Chidinma Brenda Nwatu, Chidiebere Valentine Ugwueze, Marcellinus Okafor Nkpozi, Uzoma Chukwunonso Okechukwu, Maryann Kanayo Oham, John Aniebo Maluze, Fintan Chinweike Ekochin, Ginikachi Ginikachi Ucheze Nigerian Journal of Medicine.2023; 32(4): 422. CrossRef - The prevalence of hypertension and its progression among patients with type 2 diabetes in Jordan
Ahlam Bani Salameh, Dana Hyassat, Ahmad Suhail, Zaina Makahleh, Yousef Khader, Mohammed EL-Khateeb, Kamel Ajlouni Annals of Medicine and Surgery.2022; 73: 103162. CrossRef - Gender dependent effects of fasting blood glucose levels and disease duration on biochemical markers in type 2 diabetics: A pilot study
Abhijit A. Ghadge, Arundhati G. Diwan, Abhay M. Harsulkar, Aniket A. Kuvalekar Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017; 11: S481. CrossRef - Understanding Epistatic Interactions between Genes Targeted by Non-coding Regulatory Elements in Complex Diseases
Min Kyung Sung, Hyoeun Bang, Jung Kyoon Choi Genomics & Informatics.2014; 12(4): 181. CrossRef
|